ESPN's SportsCenter anchor Jay Harris shared that he has been diagnosed with prostate cancer during an appearance on "Good ...

Longtime SportsCenter anchor Jay Harris has revealed that he is battling prostate cancer and set to undergo surgery.

ESPN's "SportsCenter" anchor Jay Harris announced on Thursday that he was diagnosed with prostate cancer and expressed ...

"PARP inhibitors have been a mainstay in the treatment of metastatic castration-resistant prostate cancer for patients with ...

The FDA approval is based on safety and efficacy demonstrated in the phase 3 ARANOTE trial, which evaluated darolutamide — ...

The viral immunotherapy delivers a replication-defective herpes simplex virus thymidine kinase gene and was administered in ...

The approval is based on results from the phase 3 ARANOTE trial, which showed Nubeqa, when combined with androgen deprivation ...

The FDA approved Nubeqa for metastatic castration-sensitive prostate cancer based on significantly improved radiographic ...

ESPN “SportsCenter” anchor Jay Harris revealed his prostate cancer diagnosis during an appearance on “Good Morning America” ...

Darolutamide (Nubeqa) is granted FDA approval for metastatic castration-sensitive prostate cancer, enhancing survival and ...

Prostate cancer remains the most common cancer in men and the second deadliest. The median age of diagnosis is 67. Yet, ...

Harris said he has received an outpouring support from his ESPN colleagues, as well as his family and friends, many of whom have shared with Harris a personal connection to prostate cancer. In Harris' ...